Figure 4From: Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferationIncreased cell death following IAP knockdown due to apoptosis. Cells were transfected with the combination of all three siRNAs targeting cIAP-1 (0.5 nM), cIAP-2 (0.5 nM), and XIAP (0.5 nM) (siTarget), or corresponding non-targeting control siRNA (0.5 nM of each control siRNA to a final concentration of 1.5 nM) (siCon). 24 hour post-transfection cells were treated with TRAIL (25 ng/ml) for a further 24 hours. Cell death was assessed by Annexin V/PI DNA staining and flow cytometry. A. Representative histograms following combined knockdown of all three IAPs (siTarget) +/- TRAIL treatment. B. Percent of cells in each quadrant (R1: PI/AV +/-, Necrotic; R2: PI/AV +/+, Late apoptotic/Necrotic; R3: PI/AV -/-, Live cells; R4: PI/AV -/+, Early apoptotic cells). Representative of three independent experiments. C. Cells were pre-treated with zVAD.fmk (100 μM) for 1 hour prior to TRAIL treatment for 24 hours. Viability was assessed by PI-DNA staining and flow cytometry. D. Following TRAIL treatment for 9 hours, cell lysates were analysed for PARP processing by Western blot. Western shown is a representative of three independent western blots.Back to article page